Full Text View
Tabular View
No Study Results Posted
Related Studies
Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus
This study has been completed.
Study NCT00093067   Information provided by Cubist Pharmaceuticals
First Received: September 30, 2004   Last Updated: February 7, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bacterial Endocarditis
Bacteremia
Additional conditions recognized in this trial
Endocarditis
Endocarditis, Bacterial
More general conditions related to this trial
Bacterial Infections
Cardiovascular Diseases
Cardiovascular Infections
Heart Diseases
Infection
Inflammation
Pathologic Processes
Sepsis
Systemic Inflammatory Response Syndrome
Interventions listed in this trial
daptomycin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Cubist Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services